SynthesisBMC neurology2020

Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis.

Jacqueline A Nicholas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.